MF
PFE icon

Manchester Financial’s Pfizer PFE Stock Holding History

Manchester Financial’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$317K Buy
13,168
+365
+3% +$9.55K 0.06% 107
2026
Q1 		$360K Buy
+12,803
New +$341K 0.07% 98
2025
Q4 		– Sell
-12,128
Closed -$309K – 143
2025
Q3 		$309K Sell
12,128
-58
-0.5% -$1.43K 0.06% 103
2025
Q2 		$295K Sell
12,186
-650
-5% -$15.2K 0.06% 98
2025
Q1 		$325K Hold
12,836
– – 0.07% 91
2024
Q4 		$341K Sell
12,836
-1,188
-8% -$32.2K 0.07% 79
2024
Q3 		$406K Sell
14,024
-24
-0.2% -$700 0.09% 67
2024
Q2 		$393K Hold
14,048
– – 0.1% 66
2024
Q1 		$390K Hold
14,048
– – 0.1% 62
2023
Q4 		$404K Buy
14,048
+5,212
+59% +$158K 0.11% 59
2023
Q3 		$293K Sell
8,836
-32
-0.4% -$1.13K 0.09% 66
2023
Q2 		$325K Buy
8,868
+1,850
+26% +$72K 0.09% 67
2023
Q1 		$286K Sell
7,018
-54
-0.8% -$2.33K 0.08% 69
2022
Q4 		$362K Sell
7,072
-626
-8% -$30K 0.1% 64
2022
Q3 		$337K Sell
7,698
-99
-1% -$4.81K 0.1% 64
2022
Q2 		$409K Sell
7,797
-564
-7% -$28.7K 0.16% 56
2022
Q1 		$433K Sell
8,361
-2,244
-21% -$116K 0.16% 57
2021
Q4 		$626K Buy
10,605
+702
+7% +$34.8K 0.22% 47
2021
Q3 		$426K Sell
9,903
-355
-3% -$15.7K 0.16% 54
2021
Q2 		$402K Buy
10,258
+50
+0.5% +$1.94K 0.16% 57
2021
Q1 		$370K Buy
10,208
+2,813
+38% +$99.9K 0.17% 48
2020
Q4 		$272K Sell
7,395
-157
-2% -$5.76K 0.17% 50
2020
Q3 		$263K Hold
7,552
– – 0.2% 42
2020
Q2 		$234K Buy
7,552
+1,558
+26% +$52.9K 0.19% 50
2020
Q1 		$186K Sell
5,994
-721
-11% -$24.6K 0.14% 57
2019
Q4 		$250K Sell
6,715
-250
-4% -$8.9K 0.1% 55
2019
Q3 		$237K Sell
6,965
-1,027
-13% -$37.3K 0.1% 53
2019
Q2 		$328K Hold
7,992
– – 0.15% 42
2019
Q1 		$322K Hold
7,992
– – 0.16% 44
2018
Q4 		$331K Buy
+7,992
New +$332K 0.18% 41

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Manchester Financial's PFE Position: Q2 2026 in Review

Manchester Financial increased its Pfizer (PFE) stake by 2.9% in Q2 2026, buying an estimated $9.55K and bringing the position to 13,168 shares worth $317K. The position accounts for 0.06% of the portfolio, ranked #107.

Manchester Financial first reported a position in PFE in Q4 2018 and has held it in 30 quarters since. The position peaked at $626K in Q4 2021. 1,324 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Manchester Financial held 13,168 shares of Pfizer worth $317K as of Q2 2026.
  • Manchester Financial bought 365 Pfizer shares in Q2 2026, an estimated $9.55K.
  • Pfizer made up 0.06% of Manchester Financial's portfolio in Q2 2026, its #107 holding.
  • Manchester Financial first reported a position in Pfizer in Q4 2018 and has held it in 30 quarters since.
  • Manchester Financial's Pfizer position peaked at $626K in Q4 2021.
  • 1,324 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Manchester Financial's 13F filing for Q2 2026, filed 17 Jul 2026.